No Survival Benefit from Annual Ovarian Cancer Screening in Low-Risk Women
The lifetime risk of developing ovarian cancer in women who are not genetically susceptible to the disease is approximately 2%.
The Women’s Cancer Research Foundation (WCRF) annually publishes and funds numerous clinical studies on breast and gynecologic (ovarian, endometrial, and cervical) cancers. The WCRF’s oncology experts work tirelessly with the belief that each new clinical study has the potential to fundamentally improve the outcomes of patients diagnosed with breast and gynecologic cancers.